Hindricks Gerhard, Tscholl Verena, Dagres Nikolaos, Attanasio Philipp, Huemer Martin
Deutsches Herzzentrum der Charité, Campus Charité Mitte, Berlin, DE, Deutschland.
Herzschrittmacherther Elektrophysiol. 2024 Mar;35(Suppl 1):110-117. doi: 10.1007/s00399-024-01009-x. Epub 2024 Feb 28.
The development and clinical implementation of catheter ablation of supraventricular tachycardia is one of the outstanding achievements of modern cardiovascular treatment. Over a period of less than 40 years, a curative and safe treatment strategy for almost all forms of atrial arrhythmias has been developed and implemented. German electrophysiologists and engineers have made a significant contribution to this truly outstanding success story in modern medicine. Their contributions should be appropriately acknowledged because without them, the development of ablation technology and its worldwide dissemination would not have been possible. Both the technological contributions and the medical-electrophysiological contributions were at the absolute forefront of worldwide developments and have made a significant contribution to the fact that today more than 500,000 patients with symptomatic and/or threatening cardiac arrhythmias can be successfully treated every year by use of catheter ablation. We would like to thank them all for their achievements.
室上性心动过速导管消融术的发展与临床应用是现代心血管治疗的杰出成就之一。在不到40年的时间里,已经开发并实施了针对几乎所有形式房性心律失常的治愈性且安全的治疗策略。德国的电生理学家和工程师为现代医学这一真正卓越的成功故事做出了重大贡献。他们的贡献应得到恰当认可,因为没有他们,消融技术的发展及其在全球的传播是不可能实现的。技术贡献和医学电生理贡献在全球发展中都处于绝对前沿,并且对如今每年有超过50万患有有症状和/或危及生命的心律失常的患者能够通过导管消融术成功治疗这一事实做出了重大贡献。我们要感谢他们所有人所取得的成就。